Share on StockTwits
 

Chemtura Corp (NYSE:CHMT) was upgraded by stock analysts at Jefferson Research from a “sell” rating to a “hold” rating in a report issued on Friday, American Banking News reports.

CHMT has been the subject of a number of other recent research reports. Analysts at Ned Davis Research upgraded shares of Chemtura Corp from a “sell” rating to a “neutral” rating in a research note on Tuesday, February 18th. Separately, analysts at Zacks downgraded shares of Chemtura Corp from an “outperform” rating to an “underperform” rating in a research note on Tuesday, February 11th. They now have a $23.20 price target on the stock. Finally, analysts at Zacks upgraded shares of Chemtura Corp from a “neutral” rating to an “outperform” rating in a research note on Monday, January 13th. They now have a $28.30 price target on the stock. Three equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $28.55.

Chemtura Corp (NYSE:CHMT) opened at 25.25 on Friday. Chemtura Corp has a 52 week low of $19.23 and a 52 week high of $28.17. The stock has a 50-day moving average of $25.22 and a 200-day moving average of $24.65. The company’s market cap is $2.439 billion.

Chemtura Corp (NYSE:CHMT) last announced its earnings results on Monday, February 24th. The company reported $0.16 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.11 by $0.05. The company had revenue of $544.00 million for the quarter, compared to the consensus estimate of $533.53 million. On average, analysts predict that Chemtura Corp will post $1.24 earnings per share for the current fiscal year.

Chemtura Corporation (NYSE:CHMT) is a diversified global developer, manufacturer and marketer of performance-driven engineered specialty chemicals.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.